Table 3. Predictors of early and late T2D remission after RYGB surgery for patients using insulin (T2D+I) preoperatively.

Early remission (partial + complete) was defined by reaching diabetes-free status during the first two months after surgery and late remission (partial + complete) was defined by reaching diabetes-free status more than two months after surgery. In univariate analysis for early remission, there were 26 variables with p-value < 0·10 (14 with p-values < 0·05). In univariate analysis for late remission, there were 33 variables with p-value < 0·10 (17 with p-values < 0·05). Individual variables were added until the models below were developed. (% EWL: percent excess body weight loss).

Early T2D remission
		Odds ratio	95% Confidence interval	p-value
Age (years)	Each 10 year decrease	2·21	[1·32, 3·70]	0·0024
Pre-operative HbA1c (%)	<6·5	6·81	[1·95, 23·86]	0·027
	6·5–6·9	3·20	[0·73, 13·98]	0·122
	7·0–8·9	1·27	[0·37, 4·44]	0·706
	9·0+	Reference	-	-
Hypertension diagnosis	Yes	0·40	[0·16, 0·99]	0·046
	No	Reference	-	-
Use of incretin mimetic agent	Yes	3·61	[1·08, 12·14]	0·038
	No	Reference	-	-
Late T2D remission
		Hazard ratio	95% Confidence interval	p-value
Post-op % EWL	Each 10% increase	1·16	[1·05, 1·29]	0·0029
Age (years)	Each 10 year decrease	1·79	[1·20, 2·63]	0·0036
Pre-operative HbA1c (%)	<6·5	3·31	[1·19, 9·18]	0·022
	6·5–6·9	1·67	[0·42, 6·75]	0·469
	7·0–8·9	1·97	[0·81, 4·83]	0·137
	9·0+	Reference	-	-